cours de bourse
14/08/2009 - 11:07:23|49.66 EUR 0.42 %
Increase in revenues in line with full-year targets (+1.2%)
Antony (France), 21 July 2014 – STALLERGENES, a global healthcare company...
Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world.
Stallergenes has a comprehensive approach of the allergic diseases with a complete portfolio combining diagnosis products and treatments and has brought the new generation of allergen immunotherapy treatments.